This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Charles River Laboratories International In (CRL)

NYSE: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 160.02M 155.93M 109.68M 68.90M
Receivables 257.99M 220.63M 206.33M 184.81M
Inventories 89.04M 89.40M 88.47M 92.97M
Other Current Assets 16.46M 11.91M 73.99M 107.00K
Total Current Assets 606.90M 552.55M 485.25M 425.84M
Property, Plant & Equipment, Gross 1.33B 1.32B 1.31B 1.29B
Accumulated Depreciation & Depletion 654.98M 645.53M 595.99M 556.64M
Property, Plant & Equipment, Net 676.80M 676.18M 717.02M 738.03M
Intangibles 178.88M 84.54M 84.92M 93.44M
Other Non-Current Assets 78.35M 65.12M 51.99M 58.64M
Total Non-Current Assets 1.28B 1.09B 1.10B 1.13B
Liabilities & Shareholder Equity
Total Assets 1.89B 1.64B 1.59B 1.56B
Accounts Payable 33.82M 31.77M 31.22M 34.33M
Short Term Debt 31.90M 21.44M 139.38M 14.76M
Other Current Liabilities 11.66M 20.70M 20.02M 11.72M
Total Current Liabilities 296.17M 247.03M 342.25M 216.80M
Long Term Debt 745.96M 642.35M 527.14M 703.19M
Deferred Income Taxes 30.82M 0.00 0.00 0.00
Other Non-Current Liabilities 136.32M 90.58M 113.76M 110.97M
Minority Interest 1.50M 1.32M 571.00K 411.00K
Total Non-Current Liabilities 916.82M 756.60M 643.29M 815.94M
Total Liabilities 1.21B 1.00B 985.54M 1.03B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 672.20M 640.98M 600.80M 525.58M
Common Par 845.00K 825.00K 796.00K 785.00K
Additional Paid In Capital 2.31B 2.21B 2.10B 2.06B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -138.78M -265.47M -368.30M -465.60M
Treasury Stock -1.42B -1.31B -1.14B -1.07B
Other Equity Adjustments -74.25M 5.36M 6.60M 4.59M
Total Capitalization 1.42B 1.28B 1.13B 1.23B
Total Equity 672.20M 640.98M 600.80M 525.58M
Total Liabilities & Stock Equity 1.89B 1.64B 1.59B 1.56B
Total Common Shares Outstanding 47.33M 47.55M 48.22M 48.88M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 37.18M 34.97M 31.39M 29.60M
Basic Weighted Shares Outstanding 46.63M 47.74M 47.91M 50.82M
Diluted Weighted Shares Outstanding 47.56M 48.49M 48.41M 51.32M
Number of Employees 7900 7700 7200 7100
Number of Part-Time Employees 0 0 0 0
CRL News

CRL Charles River Laboratories International In

Chart of CRL

Analysts Ratings for CRL

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 5 6 5
Moderate Buy 0 0 0 0
Hold 7 9 9 10
Moderate Sell 0 0 0 0
Strong Sell 2 1 1 1
GET CRL ANALYST REPORT

Brokerage Partners

CRL Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs